Our results evaluated the connection between CD93 expression and prognosis, tumor mutation burden (TMB), microsatellite instability (MSI), immune checkpoints, TME, immune cell infiltration, and immune-related genes, providing supportive evidence of its vital role in the process of cancer. This evidence concerns the gene CD93 and cancer.